Request JD-000081 Medical Affairs
Audience: Medical Affairs • completed
Routing confidence: 90% • Candidates: Medical Affairs, R&D, Commercial
Routing reasons: ML fallback: low confidence (40% < 57%); The document provides a detailed medical and historical overview of rheumatoid arthritis including discovery, treatments, research advancements, and future directions.; There is extensive reference to medical studies, drug information, and clinical treatments such as DMARDs, biologics, and JAK inhibitors.; The content includes citations from peer-reviewed sources and is framed with medically reviewed information, indicating it is intended for a medically informed audience rather than purely commercial or R&D-specific content.
Why Routed Here
Medical Affairs
at 50.2%
▼
ML predicted Medical Affairs at 50.2% confidence. Runner-up: R And D at 25.9%.
Top contributing terms (Medical Affairs)
| Term | TF-IDF | Weight | Contribution | |
|---|---|---|---|---|
healthline |
0.0851 | 0.0491 | 0.0042 | |
healthline media |
0.0824 | 0.0475 | 0.0039 | |
diagnosis |
0.0541 | 0.0693 | 0.0038 | |
read more |
0.0555 | 0.0673 | 0.0037 | |
review |
0.0304 | 0.1229 | 0.0037 | |
health |
0.0386 | 0.0878 | 0.0034 | |
older |
0.0446 | 0.0708 | 0.0032 | |
his |
0.0425 | 0.0719 | 0.0031 |
Runner-up: R And D (25.9%)
| Term | TF-IDF | Weight | Contribution | |
|---|---|---|---|---|
learning |
0.0179 | 0.2273 | 0.0041 | |
learn |
0.0463 | 0.0772 | 0.0036 | |
tools |
0.0341 | 0.0952 | 0.0032 | |
summary |
0.0436 | 0.0718 | 0.0031 | |
so |
0.0399 | 0.0733 | 0.0029 | |
much |
0.0304 | 0.0908 | 0.0028 | |
this |
0.028 | 0.0998 | 0.0028 | |
and |
0.0325 | 0.0805 | 0.0026 |
All probabilities: Commercial: 23.9% · Medical Affairs: 50.2% · R And D: 25.9%
Source url
https://www.medicalnewstoday.com/articles/rheumatoid-arthritis-history
Rheumatoid arthritis history: Discovery and development Medical News Today Health Conditions Health Conditions Alzheimer's & Dementia Anxiety Asthma & Allergies Atopic Dermatitis Breast Cancer Cancer Cardiovascular Health COVID-19 Diabetes Endometriosis Environment & Sustainability Exercise & Fitness Eye Health Headache & Migraine Health Equity HIV & AIDS Human Biology Leukemia LGBTQIA+ Men's Health Mental Health Multiple Sclerosis (MS) Nutrition Parkinson's Disease Psoriasis Sexual Health Ulcerative Colitis Women's Health Health Products Health Products All Nutrition & Fitness Vitamins & Supp…
Show full document
Rheumatoid arthritis history: Discovery and development Medical News Today Health Conditions Health Conditions Alzheimer's & Dementia Anxiety Asthma & Allergies Atopic Dermatitis Breast Cancer Cancer Cardiovascular Health COVID-19 Diabetes Endometriosis Environment & Sustainability Exercise & Fitness Eye Health Headache & Migraine Health Equity HIV & AIDS Human Biology Leukemia LGBTQIA+ Men's Health Mental Health Multiple Sclerosis (MS) Nutrition Parkinson's Disease Psoriasis Sexual Health Ulcerative Colitis Women's Health Health Products Health Products All Nutrition & Fitness Vitamins & Supplements CBD Sleep Mental Health At-Home Testing Men’s Health Women’s Health Discover News Latest News Medicare 2026 Costs Original Series Medical Myths Honest Nutrition Through My Eyes New Normal Health Podcasts All Is sleep the missing piece in mental health? Artificial sweeteners and brain aging: What we know so far Does the Mediterranean diet hold the key to longevity? AMA: Registered dietitian answers 5 key questions about fiber and weight loss Health misinformation and disinformation: How to avoid it Brain health, sleep, diet: 3 health resolutions for 2025 Tools General Health Drugs A-Z Health Hubs Newsletter Medicare Plans by State Health Tools Find a Doctor BMI Calculators and Charts Blood Pressure Chart: Ranges and Guide Breast Cancer: Self-Examination Guide Sleep Calculator Quizzes RA Myths vs Facts Type 2 Diabetes: Managing Blood Sugar Ankylosing Spondylitis Pain: Fact or Fiction Connect About Medical News Today Who We Are Our Editorial Process Content Integrity Conscious Language Find Community Bezzy Breast Cancer Bezzy MS Bezzy Migraine Bezzy Psoriasis Follow Us Subscribe Explore more in Types Treatment Home Remedies Symptoms Stages Related Conditions Prognosis Management Location Diet Diagnosis Complications Causes & Risk Factors RA Related Topics Types Types Related Articles Seropositive RA Autoimmune Arthritis Juvenile RA Seronegative RA Treatment Treatment Related Articles Surgery Actemra Amjevita DMARDs vs. Biologics Gold Injections Minocycline Enbrel (etanercept) Humira (adalimumab) Hydroxychloroquine Innovations in Treatment Chemotherapy Methotrexate Orencia (abatacept) Racial and Ethnic Disparities Remicade (infliximab) Rinvoq (upadacitinib) Steroids Biologics Treatment Overview Cyclosporine Infusion Therapy LDN for RA When to Visit Hospital Xeljanz (tofacitinib) Home Remedies Home Remedies Related Articles Ayurvedic for RA Home Remedies Overview Turmeric Essential Oils Medical Marijuana Use Symptoms Symptoms Related Articles Early Signs Dizziness and Headaches Gastrointestinal Symptoms Picture Guide Rashes Swelling Nodules Less Common Symptoms Symptoms Overview Nail Changes Juvenile RA Rash In the Fingers Stages Stages Related Articles Stages Overview Severity Scale Related Conditions Related Conditions Related Articles Fibromyalgia or RA vs Lupus vs Polymyalgia Rheumatica Hair Loss Gout Still's Disease Diabetes Fevers Osteoarthritis Brain Fog Prognosis Prognosis Related Articles Is RA a Disability? Outlook Overview Fact or Fiction History of RA Remission Management Management Related Articles Best Exercises Best Management Tools Physical Therapy Itching Attacks Shoulder Exercises Dealing with Flare-Ups Ring Splints Best Shoes Supplements Location Location Related Articles Jaw Hands Location Overview Hip Ankles Knees Wrists Back Pain Eyes Toes Neck Shoulder Diet Diet Related Articles Eggs and Arthritis Symptoms Anti-Inflammatory Diet Diet Overview Gluten Diagnosis Diagnosis Related Articles Anti-CCP Testing Blood Tests Turbid Test Diagnosis Overview CRP Levels Rheumatoid Factor Levels Complications Complications Related Articles Affect of Alcohol Anemia Complications If Untreated Fatigue Weight Loss During Pregnancy Causes & Risk Factors Causes & Risk Factors Related Articles Hot Flashes Genetics Risk Factors Overview Age of Onset Prevention The history of rheumatoid arthritis Medically reviewed by Margaret R. Li, MD, FACR — Written by Mary West on May 2, 2023 Discovery Name Past treatments Research Origins Frequency over time Summary The history of rheumatoid arthritis (RA) goes back hundreds of years. Scientists are not sure how long humans have been experiencing it, but doctors first described the condition around 1800 and named it RA in 1890. French physicians studied the condition that would become known as RA in the 19th century , learning more about it and trying early treatments, such as cold therapy and hot water baths. In 1948 , glucocorticoid treatment emerged, which reduced symptoms. Later, disease-modifying antirheumatic drugs (DMARDs) became available. These drugs slow the progression of RA. Keep reading to learn more about RA history, including its discovery, early treatment, research, and origins. Who discovered rheumatoid arthritis? Share on Pinterest Physiotherapists lower a patient with rheumatoid arthritis into a thermal pool so that they can begin exercises. © Hulton-Deutsch Collection/CORBIS/Corbis via Getty Images The first written description of RA is from the year 1800 . It came from French physician Augustin Jacob Landré-Beauvais, who wrote about his treatment of a few patients with severe joint pain. He noticed the symptoms differed from other known conditions, such as osteoarthritis and gout . Unlike gout, this type of joint pain tended to affect people who were poor and occurred more often in females than males. Landré-Beauvais believed this condition was one that medical literature had not described before. He called it “primary asthenic gout.” While his classification of the disease as a form of gout was inaccurate, his research spurred further study of the illness. In the mid to late 1800s, the English physician Alfred Garrod separated gout from other arthritic conditions. This happened when he found high levels of uric acid in the urine of people with gout but not in those with other types of arthritis. In 1859, Alfred Garrod wrote a treatise that differentiated arthritis from gout and described RA as a separate condition, which he called “rheumatic gout.” Who named the condition? One of Alfred Garrod’s sons, Archibald Garrod, was among the doctors who continued to research RA. In 1890 , he wrote a treatise on the condition but gave it a different name: rheumatoid arthritis . Garrod believed this name more accurately portrayed the condition’s effects. It describes joint inflammation (arthritis) that resembles rheumatism (rheumatoid), an old medical term for joint pain and swelling. Previously, doctors believed joint swelling occurred due to a buildup of “rheum,” or watery discharge, in the joints. This is where the words “rheumatoid” and “rheumatology” come from. What were the historical treatments? According to the historical evidence , some of the past treatments people used for RA included: Cold water therapy: This entails taking cold showers or ice baths. Some people still use this approach to relieve symptoms, using ice packs or pads on painful joints. Research from 2017 found that whole-body cold water therapy may reduce pain from inflammatory arthritis, but more studies are necessary. Hot water baths: This refers to taking a long bath in hot water. An older 2015 review investigating the value of hot baths and mineral baths did not find evidence that it is effective. Counter irritants: This involves the use of a cream that produces surface irritation on the skin, which produces warmth and reduces underlying pain, according to an older 2010 study . Bloodletting: This entails removing blood from a person through various means, such as taking it from a vein or using leeches. People have practiced bloodletting for at least 3,000 years, but in Western medicine, doctors no longer use it. Willow bark: Some ancient cultures used willow bark to relieve pain and inflammation. Willow bark contains compounds that are similar to modern-day aspirin , but despite anecdotal evidence that willow bark helps, few studies have explored its effects on RA. How did research change RA treatment? Since the discovery of RA as a distinct condition, research has led to the development of a number of evidence-based treatments for the condition, including: Glucocorticoids: In 1948 , a rheumatologist discovered that glucocorticoids, such as prednisone (Rayos), can help relieve RA symptoms and lower inflammation. Antimalarial drugs: In 1957, a doctor used chloroquine (Aralen) to treat joint inflammation. Today, doctors widely use hydroxychloroquine ( Plaquenil ) to treat many rheumatic conditions because of its effectiveness. DMARDs: These drugs can slow the progression of RA. The Food and Drug Administration (FDA) approved the first drug in this class, methotrexate (Otrexup), for RA in 1988. Biologic agents: Biologic disease-modifying agents, which are also DMARDs — such as infliximab ( Remicade ) — can inhibit a substance called tumor necrosis factor (TNF) . TNF causes inflammation and is high in people with RA. These medications came on the market in 1998. Janus kinase (JAK) inhibitors: Doctors may prescribe one of these medications for someone who cannot take methotrexate alone. The first one, tofacitinib ( Xeljanz ), came on the market in 2012. How long have humans been experiencing RA? There are differing theories about how long humans have been experiencing RA. One theory is that the condition dates back to ancient times. Archibald Garrold was a proponent of this theory and described ancient skeletal remains from Pompeii and Egypt that he believed showed signs of damage from RA. Some scientists who believe RA was present in ancient times argue that there is evidence of its existence dating back to at least 3,000 B.C.E. The ancient Greek physician Hippocrates also described a condition that resembles RA in 400 B.C.E., but at that time, doctors did not distinguish between the different types. Another theory is that RA is a modern disease, only developing due to modern lifestyles and diets. An older 2016 research article notes that it is possible both theories may be true. The authors explain that people may have had RA in ancient times, but due to a lower life expectancy, they may not have lived long enough to manifest all the symptoms. RA symptoms typically begin between the ages of 30 and 65 years. Has RA become more common over time? A 2017 study examined the incidence and prevalence of RA from 1990–2014 in the United Kingdom. According to this data, RA is not becoming more common. In fact, the authors found a decrease in the incidence and prevalence of RA in recent years. Not much earlier data exists, though, so scientists do not know if rates of RA have increased over the centuries. Summary Rheumatoid arthritis history shows that treatment has come a long way since physicians first described the condition in the 19th century. The use of glucocorticoids has helped relieve symptoms, and the advent of DMARDs has helped slow the progression in many cases. RA remains a challenging condition to live with, but due to these advances, the outlook for people with the condition has improved . There is also ongoing research that may improve RA treatment in the future, such as the development of nanoparticles, which can carry existing drugs to specific tissues in the body. Another area of future study may involve individualized targeted therapies, which are tailored to each person. This may yield better results with fewer side effects, similar to some cancer treatments. Rheumatoid Arthritis Rheumatology Bones / Orthopedics How we reviewed this article: Sources Medical News Today has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical journals and associations. We only use quality, credible sources to ensure content accuracy and integrity. You can learn more about how we ensure our content is accurate and current by reading our editorial policy . Abhishek, A., et al . (2017). Rheumatoid arthritis is getting less frequent: Results of a nationwide population-based cohort study. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850292/ Colović, N., et al . (2016). Treatment by bloodletting in the past and present [Abstract]. https://pubmed.ncbi.nlm.nih.gov/27483574/ Deshpande, S. (2014). History of rheumatology. https://www.mjdrdypu.org/article.asp?issn=0975-2870;year=2014;volume=7;issue=2;spage=119;epage=123;aulast=Deshpande Entezami, P., et al . (2011). Historical perspective on the etiology of rheumatoid arthritis. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119866/ Hinkka, H., et al . (2016). Effects of cold mist shower on patients with inflammatory arthritis: A crossover controlled clinical trial [Abstract]. https://pubmed.ncbi.nlm.nih.gov/27575584/ Hyndman, I. J. (2016). Rheumatoid arthritis: Past, present and future approaches to treating the disease. https://onlinelibrary.wiley.com/doi/10.1111/1756-185X.12823 Moore, R. A., et al . (2010). Topical analgesics for acute and chronic pain in adults. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234085/ Rheumatoid arthritis. (2021). https://rheumatology.org/patients/rheumatoid-arthritis Rheumatoid arthritis: Diagnosis, treatment, and steps to take. (2022). https://www.niams.nih.gov/health-topics/rheumatoid-arthritis/diagnosis-treatment-and-steps-to-take Shams, S., et al . (2021). The therapeutic landscape of rheumatoid arthritis: Current state and future directions. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194305/ Shara, M., et al . (2015). Efficacy and safety of white willow bark ( Salix alba ) extracts [Abstract]. https://onlinelibrary.wiley.com/doi/10.1002/ptr.5377 Verhagen, A. P., et al . (2015). Balneotherapy (or spa therapy) for rheumatoid arthritis. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045434/ Share this article Medically reviewed by Margaret R. Li, MD, FACR — Written by Mary West on May 2, 2023 Latest news AI tool may offer early warning of colorectal cancer in ulcerative colitis Daily aspirin does not lower colorectal cancer risk, review finds What's the best diet to lower cognitive decline risk? Study compares 6 diets Less plaque, higher risk? Females show greater vulnerability to cardiac events What's the hype around magnesium, and should you take supplements? Popular in: Rheumatoid Arthritis Rheumatoid arthritis and hair loss: What is the link? Can turmeric help treat rheumatoid arthritis? Stem cell therapy for rheumatoid arthritis What is seronegative rheumatoid arthritis? Exercises and remedies for Baker's cysts Related Coverage Expert perspectives: The future of management and treatment for RA Medically reviewed by Nancy Carteron, M.D., FACR Research into rheumatoid arthritis (RA) treatment is ever-evolving. Here, two rheumatology experts discuss the latest options, plus what is on the… READ MORE Can treating rheumatoid arthritis before it sets in help delay its onset? Treating high-risk people with a rheumatoid arthritis drug could help delay the condition's onset by up to 4 years, new research suggests. READ MORE Why is Humira so expensive? Medically reviewed by Jennie Olopaade, PharmD, RPH Humira is one of the world's most expensive drugs. Learn why the cost is so high, how much a 30-day supply costs, and what alternatives are available… READ MORE How does Humira work? Find out how Humira works and how long it takes to start working. READ MORE Traveling with Humira Learn how to travel with Humira, including temperature control, packing and storing the drug, TSA requirements, and international considerations. READ MORE © 2026 Healthline Media UK Ltd, London, UK. All rights reserved. MNT is the registered trade mark of Healthline Media. Healthline Media is an RVO Health Company. Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a healthcare professional. See additional information . About Us Contact Us Terms of Use Privacy Policy Privacy Settings Advertising Policy Health Topics Health Hubs Medical Affairs Content Integrity Newsletters Your Privacy Choices © 2026 Healthline Media UK Ltd, London, UK. All rights reserved. MNT is the registered trade mark of Healthline Media. Healthline Media is an RVO Health Company. Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a healthcare professional. See additional information . © 2026 Healthline Media UK Ltd, London, UK. All rights reserved. MNT is the registered trade mark of Healthline Media. Healthline Media is an RVO Health Company. Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a healthcare professional. See additional information . About Careers Advertise with us OUR BRANDS Healthline Medical News Today Greatist Psych Central Bezzy
Rheumatoid arthritis (RA) has been recognized since the 19th century with evolving treatments from cold baths to advanced DMARDs and biologics improving patient outcomes.
Full breakdown — bullets, mind map, citations, risk & scorecard
Original URL and scraped document text
One-line Summary
Rheumatoid arthritis (RA) has been recognized since the 19th century with evolving treatments from cold baths to advanced DMARDs and biologics improving patient outcomes.
Decision Bullets
-
Scientific Summary: RA pathogenesis and treatments evolved from empirical methods to targeted immunomodulation.
View citation support (1)
Since the discovery of RA as a distinct condition, research has led to the development of a number of evidence-based treatments for the condition, including: Glucocorticoids: In 1948 , a rheumatologist discovered that glucocorticoids, such as prednisone (Rayos), can help relieve RA symptoms and lower inflammation.
Offsets: 8072–8387
Confidence: 71% Medium
-
Evidence Gaps: Limited high-quality studies on early physical therapies and complementary treatments like willow bark.
View citation support (1)
Willow bark contains compounds that are similar to modern-day aspirin , but despite anecdotal evidence that willow bark helps, few studies have explored its effects on RA.
Offsets: 7862–8033
Confidence: 71% Medium
-
Medical Insights: Advanced therapies (DMARDs, biologics, JAK inhibitors) have improved disease control but require individualized approaches.
View citation support (1)
No supporting quote found.
Confidence: 20% Weak
-
Stakeholder Considerations: Access to novel treatments and cost remain barriers; education on early diagnosis is essential.
View citation support (1)
Biologics Gold Injections Minocycline Enbrel (etanercept) Humira (adalimumab) Hydroxychloroquine Innovations in Treatment Chemotherapy Methotrexate Orencia (abatacept) Racial and Ethnic Disparities Remicade (infliximab) Rinvoq (upadacitinib) Steroids Biologics Treatment Overview Cyclosporine Infusion Therapy LDN for RA
Offsets: 2047–2367
Confidence: 71% Medium
-
Next Steps: Support research on personalized medicine, novel drug delivery (e.g. nanoparticles), and long-term epidemiology of RA incidence.
View citation support (1)
No supporting quote found.
Confidence: 20% Weak
Mind Map
mindmap
root((Rheumatoid Arthritis History))
Discovery
1800(Landré-Beauvais description)
1890(Name given by Archibald Garrod)
Early Treatments
ColdWaterTherapy
HotWaterBaths
Bloodletting
WillowBark
Therapeutic Advances
Glucocorticoids(1948)
Antimalarials(1957, Hydroxychloroquine)
DMARDs(Methotrexate, 1988)
Biologics(TNF inhibitors, 1998)
JAKInhibitors(Xeljanz, 2012)
Research
Origins(Ancient theories vs modern)
Incidence(decreasing in recent UK studies)
Future
NanoparticleDrugDelivery
IndividualizedTargetedTherapies
Challenges
Access
Cost
Diagnosis
EvidenceGaps
Tags
Key Clues
- First described by Landré-Beauvais in 1800
- Named 'rheumatoid arthritis' in 1890 by Archibald Garrod
- Early treatments: cold/hot water therapy, bloodletting
- Glucocorticoids introduced 1948 improved symptoms
- Methotrexate FDA-approved DMARD in 1988
- Biologics (TNF inhibitors) available since 1998
- JAK inhibitors introduced in 2012 for refractory RA
Citation & Risk Scorecard
| # | Bullet | Supporting Quote | Level |
|---|---|---|---|
| 1 |
Scientific Summary: RA pathogenesis and treatments evolved from empirical methods to targeted immunomodulation.
|
"Since the discovery of RA as a distinct condition, research has led to the development of a number of evidence-based treatments for the condition, including: Glucocorticoids: In 1948 , a rheumatologist discovered that glucocorticoids, such as prednisone (Rayos), can help relieve RA symptoms and lower inflammation."
|
Medium |
| 2 |
Evidence Gaps: Limited high-quality studies on early physical therapies and complementary treatments like willow bark.
|
"Willow bark contains compounds that are similar to modern-day aspirin , but despite anecdotal evidence that willow bark helps, few studies have explored its effects on RA."
|
Medium |
| 3 |
Medical Insights: Advanced therapies (DMARDs, biologics, JAK inhibitors) have improved disease control but require individualized approaches.
|
— | None |
| 4 |
Stakeholder Considerations: Access to novel treatments and cost remain barriers; education on early diagnosis is essential.
|
"Biologics Gold Injections Minocycline Enbrel (etanercept) Humira (adalimumab) Hydroxychloroquine Innovations in Treatment Chemotherapy Methotrexate Orencia (abatacept) Racial and Ethnic Disparities Remicade (infliximab) Rinvoq (upadacitinib) Steroids Biologics Treatment Overview Cyclosporine Infusion Therapy LDN for RA"
|
Medium |
| 5 |
Next Steps: Support research on personalized medicine, novel drug delivery (e.g. nanoparticles), and long-term epidemiology of RA incidence.
|
— | None |
Risk & Compliance
anecdotal evidence
Suggestion: Patient anecdotes are not clinical evidence; cite controlled trial data instead.
Metadata (Attempts & Trace Legend)
Attempt Timeline
Attempts
-
Attempt 1 —
Passed
Rheumatoid arthritis (RA) has been recognized since the 19th century with evolving treatments from cold baths to advanced DMARDs and biologics improving patient outcomes.
Trace Legend
- Route Audience: Classifies the document into an audience.
- Specialist Generate: Produces one-line summary, key clues, decision bullets, mind map, and tags.
- Evaluate: Checks required sections, word count, and 3–5 bullet constraint.
- Persist Attempt: Saves the attempt record.
- Next Step: Decides whether to revise or persist results.
- Persist Results: Saves final clues and tags at the document level.